my report listening to the investor conference, page-4

I have not seen many people talking about the medical aspect of the treatment , what they have be talking about is the reglutory requirements that you need to pass to get the treatment to market.
These hurdles will be the things that have the greatest affect on the share price and the way the market views the company.
Most don't want to know how the treatment works (you would need to be a medical expert to understand this fully) but they do want to know if it works and the trials provide the means to tell us IF the treatment works.
This is a share forum isn't it , surely everyone wants to know and understand the information which will affect the price of their investment.
Why would you not want to focus on the area's that will drive the market interest and the share price????????